Mutual Fund Details

DSP Healthcare Fund Direct - Growth

Name: DSP Healthcare Fund Direct - Growth
Brand: DSP Mutual Fund

Equity Pharma

NAV

₹43.8430

as on 18 Nov 2024, 09:00 PM

₹-0.3020(0.68%)

Last Change

Scheme Ratings

Pharma

5Y Returns

rated by Value Research

Pharma

Rankings based on 5Y Returns | as on 18 Nov 2024

DSP Healthcare Fund Direct - Growth

32.21%

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

31.08%

Mirae Asset Healthcare Fund Direct - Growth

30.07%

SBI Healthcare Opportunities Fund Direct Plan-Growth

29.84%

UTI Healthcare Fund Direct-Growth

28.72%

Schemes Managed By

Chirag Dagli

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,76,997

₹1,84,361

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹84,361

Profit (absolute return)

84.36%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

6.41%

In the last 6 months

22.78%

In the last 1 year

47.41%

In the last 3 years

84.36%

In the last 5 years

304.57%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

DSP Healthcare Fund Direct - Growth

as of 31 Oct 2024, 05:30 AM

₹3,138.46 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.50% if redeemed within 1 month.

0.59%

Expense Ratio

Plan

Growth

2.73%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 0.50% if redeemed within 1 month.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

95.12%

₹2,985.31 Cr

Insurance

1.47%

₹46.14 Cr

Others

3.41%

₹107.02 Cr

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

95.12%

₹2,985.31 Cr

Insurance

1.47%

₹46.14 Cr

Others

3.41%

₹107.02 Cr

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.50%

₹392.31 Cr

Suven Pharmaceuticals Ltd.

9.38%

₹294.39 Cr

Cipla Ltd.

8.28%

₹259.86 Cr

Ipca Laboratories Ltd.

7.31%

₹229.42 Cr

Lupin Ltd.

7.14%

₹224.09 Cr

Others

55.39%

₹1,738.40 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.50%

₹392.31 Cr

Suven Pharmaceuticals Ltd.

9.38%

₹294.39 Cr

Cipla Ltd.

8.28%

₹259.86 Cr

Ipca Laboratories Ltd.

7.31%

₹229.42 Cr

Lupin Ltd.

7.14%

₹224.09 Cr

Others

55.39%

₹1,738.40 Cr

View All

Funds in this Category

This fund's returns:

22.60%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About DSP Healthcare Fund Direct - Growth

DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Chirag Dagli. It has an AUM of ₹3,138.46 Crores and the latest NAV decalared is ₹43.843 as on 20 Nov 2024 at 11:09 am.

DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 47.41%, in last 3 years is 84.36% and 336.08% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.